华安医疗创新混合C(013483)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
176,829,460.86 |
158,106,687.31 |
-102,801,219.53 |
-94,003,403.88 |
| 利息合计 |
155,714.75 |
87,098.49 |
370,824.42 |
188,764.01 |
| 其中:存款利息收入 |
155,714.75 |
87,098.49 |
370,824.42 |
188,764.01 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
181,928,607.97 |
95,218,556.70 |
-58,259,486.93 |
-54,369,914.93 |
| 其中:股票投资收益 |
177,848,716.56 |
92,980,277.21 |
-66,265,651.49 |
-59,993,952.10 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
146,645.33 |
50,001.54 |
270,479.94 |
324.13 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,933,246.08 |
2,188,277.95 |
7,735,684.62 |
5,623,713.04 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-5,926,917.80 |
62,623,301.50 |
-45,124,347.21 |
-39,945,797.87 |
| 其他收入 |
672,055.94 |
177,730.62 |
211,790.19 |
123,544.91 |
| 费用 |
8,208,687.23 |
3,760,822.21 |
10,364,717.24 |
5,622,847.15 |
| 管理人报酬 |
6,427,893.51 |
2,995,754.14 |
7,978,288.05 |
4,322,710.42 |
| 基金托管费 |
1,071,315.55 |
499,292.34 |
1,329,714.63 |
720,451.74 |
| 销售服务费 |
463,901.76 |
148,811.76 |
820,839.03 |
446,646.08 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
245,576.41 |
116,963.97 |
235,873.25 |
133,037.74 |
| 利润总额 |
168,620,773.63 |
154,345,865.10 |
-113,165,936.77 |
-99,626,251.03 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年